AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02948348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Capecitabine:Dose of 1650mg/m2,14days, Radiation:45Gy/25 fractions, Nivolumab :240mg on day1 of each cycle, Surgical therapy:The resection (LAR), intersphincteric resection (ISR), or abdominoperineal resection (APR).
Study NCT01740336 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered IV weekly for 3 out of 4 weeks in every 28-day cycle.
Study NCT01740336 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel will be administered IV weekly for 3 out of 4 weeks in every 28-day cycle.
Study NCT02948348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: For only Cohort D,1 mg/kg at six-week intervals
Study NCT03849716 — intervention group
Intervention type: OTHER
Intervention: Blood sample
Description: Blood samples obtained for biomarker analyses
Study NCT03849716 — intervention group
Intervention type: OTHER
Intervention: Cheek swab
Description: Cheek swab obtained for genetic analysis
Study NCT03444220 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Anaerobically Cultivated Human Intestinal Microbiota
Description: 30ml ACHIM will be administrated at week 0 and 2 with 14 days apart
Study NCT03444220 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Anaerobically Cultivated medium
Description: 30ml medium will be administrated at week 0 and 2 with 14 days apart
Study NCT02711176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nexium
Description: Patients in experimental group will receive the 14 day single dose of Nexium 40 mg daily
Study NCT02711176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tinafas
Description: Patients in experimental group will receive the 14 day single dose regimen of Tinafas 1 g daily
Study NCT02711176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tavanex
Description: Patients in experimental group will receive the 14 day single dose of Tavanex 500 mg daily
Study NCT02711176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lanzol
Description: Patients in active comparator group will receive the 14 day lansoprazole (Lanzol) 30 mg twice daily
Study NCT02711176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Klacid
Description: Patients in active comparator group will receive the 14 day clarithromycin (Klacid) 500 mg twice daily twice daily
Study NCT02711176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iramox
Description: Patients in active comparator group will receive the 14 day amoxicillin (Iramox) 1 g twice daily
Study NCT02707770 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation
Study NCT02707770 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pulmonary Rehabilitation
Study NCT03450213 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Pentacam
Description: Pentacam will be used to measure the magnitude and axis orientation of anterior and posterior corneal astigmatism.
Study NCT03450213 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pentacam
Description: Pentacam will be used to measure the magnitude and axis orientation of anterior and posterior corneal astigmatism.
Study NCT03059693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAT1 topical cream
Study NCT03059693 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle cream
Study NCT03673371 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: This is a questionnaire developed by DoD and VA researchers specifically for this study.
Study NCT02320786 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CoPILOT
Description: Participants in both groups will receive twelve hours of training in a standard powered wheelchair however the CoPILOT groups will use remote control technology we have developed. The technology provides the trainer with remote control of wheelchair speed and direction allowing the trainer to override the participant's actions as needed to ensure safe error-free shared controlled wheelchair training. The CoPILOT approach will accommodate varied learning needs, as per adult learning principles, while decreasing trainer input until the participant can complete tasks independently.
Study NCT00027690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gefitinib
Description: Given orally
Study NCT00027690 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01542541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin
Description: 550mg BID for 2 days
Study NCT02144649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: dietary intervention (tangerine tomato juice)
Description: Group II will consume two 5.5 oz. cans of tangerine tomato juice every day until their scheduled surgery. (approximately 4 weeks).
Study NCT02144649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: dietary intervention (red tomato juice)
Description: Group III will consume two 5.5 oz. cans of red tomato juice every day until their scheduled surgery (approximately 4 weeks).red tomato juice
Study NCT02144649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Men enrolled in the study will be asked to complete a 3-Day Food Record and a series of additional questionnaires (urologic symptom and quality of life questionnaire) at home.
Study NCT01364402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epoetin beta
Description: 50,000U intravenously
Study NCT01364402 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline 0.9%
Description: normal saline intravenously
Study NCT04151693 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Psychological Group Rehabilitation for Patients With Chronic Fatigue Syndrome (ME/CFS)
Description: Adaptation (support own agency), rehabilitation and improvement of functional capacity.
Study NCT03800966 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Leaflet
Description: Leaflets for both groups will be printed in colour. Leaflet in each group contains 8 pictures and 8 statement, whose sequences will be scrambled. Primary school students need to do the matching, to ensure they read the statements.
Study NCT03800966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Leaflet
Description: Leaflets for both groups will be printed in colour. Leaflet in each group contains 8 pictures and 8 statement, whose sequences will be scrambled. Primary school students need to do the matching, to ensure they read the statements.
Study NCT03241043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment 2 weeks Envarsus followed by 2 weeks Advagraf
Study NCT03241043 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment 2 weeks Advagraf followed by 2 weeks Envarsus
Study NCT01315275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Study NCT04048070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flurbiprofen Axetil
Description: One kind of NSAIDs, 200mg for 48 hours after surgery.
Study NCT04048070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: One kind of opioid drugs, 1.5μg/kg, and recorded the drug consumption after surgery
Study NCT04048070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Extended perioperative counseling
Description: The extended perioperative counseling contained additional information, including surgery procedures, importance of medicine treatment and medical help to relieve depression and anxiety about disease during peri-operation period.
Study NCT04048070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shorter fasting food and water time before surgery
Description: The patients in ERAS group were required to fast food for 6 to 8 hours and provided 12.6% maltodextrin carbohydrate supplement beverage for 2 hours before surgery
Study NCT04048070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional perioperative counseling
Description: THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.
Study NCT04048070 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Conventional perioperative counseling
Description: THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.
Study NCT02144649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Correlative studies
Description: Blood and urine samples at enrollment and blood, urine, and prostate tissue at the time of surgery to determine compliance with the intervention product and tomato phytochemical biodistribution. Additionally, we will correlate each type of tomato juice with lycopene presence in plasma, urine, and tissue provided by subjects on the day of surgery.
Study NCT02602509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Study NCT04048070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular fasting food and water time before surgery
Description: The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.
Study NCT04048070 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Regular fasting food and water time before surgery
Description: The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.
Study NCT01863602 — intervention group
Intervention type: DRUG
Intervention: Lamotrigine tablets
Description: Administered for long-term according to the prescribing information in the locally approved label by the authorities.
Study NCT03146481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aceclofenac
Description: Aceclofenac 100 mg tablet given one hour before starting the root canal treatment
Study NCT03146481 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet given one hour before starting the root canal treatment
Study NCT02602509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin
Study NCT02602509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrazinamide
Study NCT03220412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movies with Guns
Description: Participants in this arm viewed movies (National Treasure, The Rocketeer) without guns. The movies, rated PG, were edited to remove guns from the scenes
Study NCT03739970 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Investigational Product (Silk Peptide)
Description: * Ingredient: Silk Peptide~* Type: Yellow granule stick~* Storage: Room temperature~* Weight: Silk Peptide 9g/day~* Directions: with water before breakfast and dinner, 9g/day (4.5g×2times/day)~* Duration of use: 8 weeks
Study NCT03739970 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Group - Placebo Product
Description: * Ingredient: Microcrystalline Cellulose~* Type: Yellow granule stick~* Storage: Room temperature~* Weight: Silk Peptide 0g/day~* Directions: with water before breakfast and dinner, 9g/day (4.5g×2times/day)~* Duration of use: 8 weeks
Study NCT04057443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional support
Description: Nutritional support will be given to all patients according with their nutritional body composition parameters (Nutritional assessment and sarcopenia evaluation). It could be diet counselling, oral supplemented nutrition, enteral nutrition o parenteral nutrition.
Study NCT04057443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: The exercise program, designed, applied and monitored by research staff of the Physiology Unit, will have duration of 24 weeks (6 months). The program will have a mixed structure, the participants in an individual way fulfill their training and attend group sessions (8 subjects). In addition, 3 days a week should conduct sessions that will focus on the work of balance and general strength.
Study NCT04057443 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hematologic Drug
Description: The patients of the control group will follow the standard treatment and follow-up according to the clinical protocol of the institution.
Study NCT04057443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hematologic Drug
Description: The patients of the control group will follow the standard treatment and follow-up according to the clinical protocol of the institution.
Study NCT03265691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early detection and treatment of hyponatremia
Description: In the experimental group, hyponatremia will be diagnosed and treated early. Therefore, the researchers will review the patients' sodium levels at admission and throughout their stay.
Study NCT03265691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No Intervention (SOC)
Description: Usual pattern of work will be performed in all patients who enter in Hospital.
Study NCT01752283 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: video-assisted thyroidectomy
Description: Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis
Study NCT01752283 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: video-assisted thyroidectomy
Description: Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis
Study NCT02531295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Euphorbia kansui extract powder prepared as tea
Description: 1 g of Euphorbia kansui extract powder, measured and reconstituted in 4 fluid ounces of boiled water allowed to cool and administered as tea, taken by mouth daily
Study NCT05451381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: sedation after cardiac surgery
Study NCT05451381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: sedation after cardiac surgery
Study NCT05451381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and Propofol
Description: sedation after cardiac surgery
Study NCT02835443 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation
Description: Electrical stimulation of the dentate nucleus area of the cerebellum.
Study NCT03918239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHP643
Description: Participants will receive injection of SHP643.
Study NCT01714596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PO versus IV antibiotics Route of administration evaluation
Description: This is a study of oral (per os, (PO)) antibiotic therapy versus intravenous (IV) antibiotics in the treatment of acute infection after fixation of fractures and joint fusions. This is not a study of an experimental drug but a study of route of administration of standard use antibiotics. Antibiotic regimen options decision will be made by the Study Surgeon at each site in consult with local Infectious Disease experts based on local standard practices and bacterial susceptibilities.
Study NCT00781742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD6765
Description: IV once per dosing day, multiple times during the treatment period
Study NCT00781742 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% saline IV once per dosing day multiple times during the treatment period
Study NCT00963989 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Penumbra System
Description: The Penumbra System is used to revascularize clotted cerebral blood vessels.
Study NCT01301768 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group Education
Description: Group educational workshops about dietary habits in the first trimester because it is when organogenesis occurs and therefore when the iodine deficiency in the mother is an important risk in the development of the fetal central nervous system.
Study NCT03069820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel and cisplatin
Description: Patients receive TP (docetaxel and cisplatin) chemotherapy
Study NCT01492179 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline would be administered intravenously and intra-abdominally.
Study NCT01492179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Lidocaine
Description: Standardized infusion of lidocaine during 24 h. 100 mg bolus and 50 mg/h during 24 h would be administered.
Study NCT01492179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intra-abdominal Lidocaine
Description: Lidocaine 5 mg/ml; 100 mg would be administered intraoperatively intra-abdominally and subsequently 50 mg/h as intermittent injection intra-abdominally during 24 h
Study NCT04057820 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Finnegan Neonatal Abstinence Scoring Tool
Description: The FNAST is a scoring system used in neonatal units to initiate and guide therapy in infants of opiate-dependent mothers.
Study NCT01752283 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Video-assisted thyroidectomy
Description: video-assisted thyroidectomy under general anesthesia
Study NCT01752283 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Video-assisted thyroidectomy
Description: video-assisted thyroidectomy under general anesthesia
Study NCT02360761 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracotomy
Description: Patients undergo lobectomy, wedge resection, or anatomic segmentectomy by thoracotomy.
Study NCT02360761 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thoracotomy
Description: Patients undergo lobectomy, wedge resection, or anatomic segmentectomy by thoracotomy.
Study NCT02516839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regulation of Cues (ROC)
Description: Participants are provided information about basic learning theory and how physiological responses to food cues develop and can be managed. Lack of sensitivity to appetite and satiety cues and increased sensitivity to food cues will be discussed. Coping skills are presented to assist in mastery and toleration of food cue sensitivity. Participants will complete experiential learning exercises with food, and taught to monitor their hunger,satiety, and cravings. The physical activity program will focus on increasing both lifestyle activity and structured exercise programs.
Study NCT00135421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pexacerfont
Description: Tablets \& Capsules, Oral, 100 mg, Once daily, Up to 8 weeks followed by 8 weeks of observation
Study NCT00135421 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Escitalopram
Description: Tablets \& Capsules, Oral, 20 mg, Once daily, Up to 8 weeks followed by 8 weeks of observation.
Study NCT02516839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss (BWL)
Description: All participants will be instructed on how to consume a balanced deficit diet of conventional foods; individual goals for energy intake will be based on initial body weight. Participants will be instructed in measuring portion sizes, counting calories (with a calorie counter provided or on their phone), and self-monitoring food intake. The physical activity program will focus on increasing both lifestyle activity and structured exercise programs. Behavior change recommendations include stimulus control, self-monitoring, goal setting, managing high-risk situations, meal planning, slowing eating, problem solving, social support, cognitive restructuring, lapse and relapse prevention skills, and maintaining weight loss.
Study NCT02516839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BWL + ROC
Description: BWL and ROC will be integrated for this arm, to capitalize on the strengths of both treatments. All participants will be taught to decrease caloric intake and increase physical activity, and to use all of the behavioral skills provided in BWL. However, they will also be taught models of hunger and satiety and about food cue reactivity, and will learn skills to manage these. This arm will include an experiential component, including hunger monitoring during dinner and participating in exposure sessions in the clinic.
Study NCT02516839 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition Education, Stress Management and Social Support
Description: Topics included will be stress management/relaxation, social support, and nutrition education. There will be a strong mindfulness component to this group.
Study NCT00804960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: 1) Letrozole 5 mg starting on cycle day 2, which will be continued until the day of trigger. Recombinant FSH at doses 100-225 units, as determined by BMI, AFC, age, and ovarian reserve markers will be added on cycle day 4. The dose will be adjusted based on the response. An antagonist will be administered once the lead follicle reaches 14-mm in diameter or when estradiol level reaches 250 pg/mL. Oocyte maturation will be triggered by 20 iu of leuprolide acetate.
Study NCT00804960 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Std IVF Protocol
Description: 2) Long protocol with luteal phase GnRHa suppression with gonadotropin dose at 200-450 IU. Oocyte maturation will be triggered by 250 micg of ovidrel.